First, new doses of DSS and new IBD induction protocols (acute versus chronic colitis) should be tested to evaluate better the impact of L. lactis expressing p62 on these models, using different approaches for the treatments and prevention. The gene discussed is SQSTM1; the disease is Chronic colitis.